I think there's a good chance we recover to $.40+ this week. Should continue inching up towards the ASM in early December.
With regards to NASH, remember Dr. Noureddin and Dr. Recknor will be attending the AASLD conference at the end of the week. More exposure for Leronlimab and Cytodyn.